Scandinavian Medical Solutions A/S

CPSE:SMSMED Stock Report

Market Cap: DKK 173.3m

Scandinavian Medical Solutions Valuation

Is SMSMED undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SMSMED when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SMSMED's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SMSMED's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SMSMED?

Key metric: As SMSMED is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SMSMED. This is calculated by dividing SMSMED's market cap by their current earnings.
What is SMSMED's PE Ratio?
PE Ratio32.3x
EarningsDKK 5.37m
Market CapDKK 173.26m

Price to Earnings Ratio vs Peers

How does SMSMED's PE Ratio compare to its peers?

The above table shows the PE ratio for SMSMED vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average24.3x
QMSMEDI QMS Medical Allied Services
20xn/a₹2.0b
WINMED Winnergy Medical
28.4xn/a฿788.0m
SEI SEI Medical
29.7x32.5%฿795.6m
INDIES Indies Pharma Jamaica
19.2xn/aJA$4.1b
SMSMED Scandinavian Medical Solutions
32.3xn/aDKK 173.3m

Price-To-Earnings vs Peers: SMSMED is expensive based on its Price-To-Earnings Ratio (32.3x) compared to the peer average (24.3x).

Price to Earnings Ratio vs Industry

How does SMSMED's PE Ratio compare vs other companies in the European Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
SMSMED 32.3xIndustry Avg. 18.6xNo. of Companies9PE01020304050+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: SMSMED is expensive based on its Price-To-Earnings Ratio (32.3x) compared to the European Healthcare industry average (18.6x).

Price to Earnings Ratio vs Fair Ratio

What is SMSMED's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SMSMED PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio32.3x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SMSMED's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies